These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9769565)

  • 1. Rheumatologic manifestations of HIV-1 and HTLV-1 infections.
    Vassilopoulos D; Calabrese LH
    Cleve Clin J Med; 1998 Sep; 65(8):436-41. PubMed ID: 9769565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The rheumatological manifestations of infection with the human immunodeficiency virus (HIV)].
    Gheorghiu O; Suţeanu S
    Med Interna; 1992; 44(1):40-4. PubMed ID: 1345349
    [No Abstract]   [Full Text] [Related]  

  • 3. Rheumatologic manifestations of infection with the human immunodeficiency virus (HIV).
    Buskila D; Gladman DD; Langevitz P; Bookman AA; Fanning M; Salit IE
    Clin Exp Rheumatol; 1990; 8(6):567-73. PubMed ID: 2289325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of human T cell lymphotrophic virus (HTLV) type I and II DNA in French anti-HTLV-I/II-negative intravenous drug users.
    Lefrère F; Wattel E; Mariotti M; Agis F; Gordien E; Lefrère JJ
    J Infect Dis; 1992 Jul; 166(1):212-3. PubMed ID: 1607702
    [No Abstract]   [Full Text] [Related]  

  • 5. HTLV-I and HIV-1 infection in patients with lymphadenopathy syndrome detected during routine breast screening at a tumor prevention center.
    Manzari V; Modesti M; De Marchis L; Gradilone A; Cifaldi L; Marchei P
    AIDS Res Hum Retroviruses; 1990 Mar; 6(3):417-21. PubMed ID: 2340202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple infection with HIV-1, HTLV-1 and Strongyloides stercoralis, rendering CD4+ T-cell counts a misleading entity.
    Janssen S; Rossatanga EG; Jurriaans S; ten Berge IJ; Grobusch MP
    Antivir Ther; 2013; 18(7):949-51. PubMed ID: 24152969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute myelitis as presenting symptom of HIV-HTLV-1 co-infection.
    Cucca A; Stragapede L; Antonutti L; Catalan M; Caracciolo I; Valentinotti R; Granato A; D'Agaro P; Manganotti P
    J Neurovirol; 2016 Dec; 22(6):861-865. PubMed ID: 27245591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA inoculation as a novel vaccination method against human retroviruses with rheumatic disease associations.
    Ugen KE; Wang B; Ayyavoo V; Agadjanyan M; Boyer J; Li F; Kudchodkar S; Lin J; Merva M; Fernandes L
    Immunol Res; 1994; 13(2-3):154-62. PubMed ID: 7775806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia.
    El-Hazmi MM
    Saudi Med J; 2004 Jan; 25(1):26-33. PubMed ID: 14758374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive multifocal leukoencephalopathy in a HIV/HTLV co-infected patient.
    Santos EM; Silva MT; Lima MA
    J Neurol Sci; 2013 Feb; 325(1-2):174-5. PubMed ID: 23294497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HTLV-1, ATLL, severe hypercalcaemia and HIV-1 co-infection: an overview.
    Laher AE; Ebrahim O
    Pan Afr Med J; 2018; 30():61. PubMed ID: 30344845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rheumatologic manifestations of pediatric human immunodeficiency virus infection.
    Schuval SJ; Bonagura VR; Ilowite NT
    J Rheumatol; 1993 Sep; 20(9):1578-82. PubMed ID: 8164219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Viral infections--clinical pictures and laboratory diagnosis. Part 5: Human immunodeficiency virus (HIV 1, HIV 2) to measles virus].
    Burkhardt U; Eggers HJ
    Fortschr Med; 1993 Dec; 111(35-36):559-61. PubMed ID: 8307545
    [No Abstract]   [Full Text] [Related]  

  • 14. HIV and HTLV-1 co-infection.
    Goorney BP; Young AC
    Int J STD AIDS; 2000 Mar; 11(3):205-6. PubMed ID: 10726953
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pathologies associated with HTLV-1 virus in Dakar (1992-1995)].
    Michel P; Develoux M; Talarmin F; Ndiaye P; Ndiaye M; Raphenon G; Le Guenno B; Gessain A
    Med Trop (Mars); 1996; 56(3):249-54. PubMed ID: 9026591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphologic and immunoelectronmicroscopic identification of human T-cell lymphotropic virus type III (HTLV-III).
    Timár J; Nagy K; Lapis K
    Histol Histopathol; 1986 Jan; 1(1):43-7. PubMed ID: 2856534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low prevalence of human T-lymphotrophic virus type I (HTLV-I) in HIV-positive patients in Kenya.
    Songok EM; Tukei PM; Libondo D; Gichogo A; Oogo SA
    J Acquir Immune Defic Syndr (1988); 1994 Aug; 7(8):876-7. PubMed ID: 8021826
    [No Abstract]   [Full Text] [Related]  

  • 18. Seroprevalence and molecular epidemiology of HTLV-1 isolates from HIV-1 co-infected women in Feira de Santana, Bahia, Brazil.
    de Almeida Rego FF; Mota-Miranda A; de Souza Santos E; Galvão-Castro B; Alcantara LC
    AIDS Res Hum Retroviruses; 2010 Dec; 26(12):1333-9. PubMed ID: 20929351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A recombinant protein based immunoassay for the combined detection of antibodies to HIV-1, HIV-2 and HTLV-I.
    Benítez J; Palenzuela D; Rivero J; Gavilondo JV
    J Virol Methods; 1998 Jan; 70(1):85-91. PubMed ID: 9506816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of human immunodeficiency virus (HIV) and human lymphotropic virus (HTLV) type I or II dual infections by polymerase chain reaction.
    De BK; Srinivasan A
    Oncogene; 1989 Dec; 4(12):1533-5. PubMed ID: 2594369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.